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Pyruvate kinase is one of the enzymes which can be phosphorylated bystimulation of the cell with either 
glucagon or Ca 2 ÷-linked hormones. Whether these two classes of hormones phosphorylate he same site 
on the enzyme is unclear. Our results demonstrate hat isolation of [32p]phosphorylated ype-L pyruvate 
kinase from glucagon-treated hepatocytes followed by aspartyl-prolyl cleavage yields a [32p]phosphorylated 
peptide of Mr 17000. This fragment is also phosphorylated in response to the Ca2+-mediated agonist 
phenylephrine. 
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1. INTRODUCTION 
Pyruvate kinase (ATP:pyruvate O2-phospho - 
transferase, EC 2.7.1.40) plays an important role 
in the control of hepatic metabolism, since regula- 
tion of its activity can influence the rates of 
gluconeogenesis and of glycolysis [1]. 
Liver pyruvate kinase can be phosphorylated, 
with a resultant inactivation, by a cAMP- 
dependent protein kinase [2]. In vivo experiments 
have shown partial inactivation of rat type-L 
pyruvate kinase (L-PK) within a few minutes of in- 
travenous injection of glucagon [3]. There is now 
clear evidence that phosphorylation f the enzyme 
is stimulated by glucagon both in vivo and in vitro 
[1]. 
Recently, studies have demonstrated that hor- 
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mones can regulate hepatic carbohydrate 
metabolism through two distinct pathways. 
Glucagon appears to act via cAMP and cAMP- 
dependent protein kinase, whilst a-adrenergic 
agonists (such as vasopressin and angiotensin II) 
are thought o  utilize a Ca2+-linked pathway that 
is independent of cAMP [4,5]. 
Pyruvate kinase is one of the enzymes which can 
be phosphorylated by stimulation of the cell with 
either glucagon or CaE+-linked hormones [6]. At 
the present time, it is unclear if L-PK is 
phosphorylated at the same site by the two dif- 
ferent hormonal effector systems. By comparison 
the rabbit muscle glycogen synthetase is known to 
possess multiple sites for phosphorylation [7]. 
Phosphorylation of L-PK by calcium/calmodulin- 
dependent protein kinase II has been shown to 
modify both serine and threonine residues in a 
3-4 kDa CNBr fragment near the amino-terminus 
[8]. 
We have used immunological techniques to 
isolate L-PK from hepatocytes exposed to dif- 
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Fig. 1. Autoradiographs of SDS-PAGE gels of phosphorylated L-PK before (a) and after (b) aspartyl-prolyl cleavage. 
(a) Varying amounts (0.5, 1, 2/~g) of protein obtained by Sepharose-Procion blue MX-R chromatography were applied 
to tracks 1-3. Track 4 contains reference markers (68, 57, 49, 35, 29, 18 14 kDa). (b) Tracks 2-4 each contain 1.2/~g 
L-PK after aspartyl-prolyl cleavage. Tracks 1 and 5 contain the same reference markers as in (a). 
ferent hormones in an attempt to study the 
phosphorylation state of the enzyme. 
2. MATERIALS AND METHODS 
2.1. Enzyme isolation 
L-PK was purified from livers of high- 
carbohydrate diet fed rats [9] and used to raise anti 
L-PK antibody. The partially purified im- 
munoglobulin was raised in sheep and prepared ac- 
cording to Hudson and Hay [10]. Rat liver 
cytosolic protein kinase was partially purified 
essentially by the method of Chen and Walsh [11]. 
[32p]Phosphorylated L-PK was isolated either by 
affinity chromatography using a Sepharose-Blue 
MX-R column [9] or by immunoprecipitation [12]. 
Cleavage of aspartyl-prolyl bonds in L-PK was ef- 
fected by hydrolysis in 75°7o formic acid [13]. 
2.2. Isolation and incubation of hepatocytes 
Hepatocytes were isolated from high- 
carbohydrate diet fed rats following perfusion with 
collagenase [14]. Incubation of cells followed the 
protocol described by Postle and Bloxham [12]. 
The incubation was terminated by adding an equal 
volume of buffer A (50 mM potassium phosphate, 
100mM KCI, 50mM NaF, 5mM EDTA and 
1 mM DTT, pH 7.4) saturated with ammonium 
sulphate. The cells were homogenized and the pro- 
tein precipitate collected by centrifugation at 
10000 x g for 15 min at 4°C. The protein pellet 
was dissolved in buffer A alone. Insoluble protein 
and cell debris were removed by centrifugation 
(10000 × g for 15 min) and the supernatant col- 
lected. This supernatant, containing > 80% of the 
L-PK present in the cell extract, waS' dialysed 
against buffer A overnight. 
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Fig.2. SDS-PAGE of proteins present at different stages 
of isolation by immunoprecipitation of L-PK. Tracks 4 
and 5 refer to protein originating from glucagon-treated 
hepatocytes whilst tracks 9 and 10 originated from 
control hepatocytes. The proteins present after the 50% 
ammonium sulphate fractionation are shown in tracks 4 
and 10, and those remaining after immunoprecipitation 
of this fraction are shown in tracks 5 and 9. Track 6 
contains the anti L-PK immunoglobulin alone and track 
8 contains muscle PK as a marker. Tracks 1, 7 and 13 
contain molecular mass markers as used in fig. 1. The gel 
was stained for protein using Coomassie brilliant blue 
R-250. 
3. RESULTS 
3.1. Phosphorylation of  L-PK in vitro by 
cAMP-dependent protein kinase 
L-PK was phosphorylated using partially 
purified protein kinase in vitro. Approx. 50 units 
of the L-PK was dialysed overnight against 5 mM 
potassium phosphate (pH 7.2), 5 mM magnesium 
acetate, 20070 (v/v) ethylene glycol and 1 mM 
EDTA. The enzyme was then incubated in the 
presence of 17 mM potassium phosphate, pH 6.8; 
6/zM cAMP, 0.3 mM [7-32p]ATP (10 Ci), 6 mM 
magnesium acetate in a final volume of 3 ml. 
200/~l protein kinase (12 mg/ml) as its ammonium 
sulphate suspension was added and the mixture in- 
cubated at 37°C for 15 min. Subsequently, 
[32p]phosphorylated L-PK was isolated by affinity 
chromatography on a Sepharose-Blue MX-R col- 
umn (fig.la)~ The fractions containing [32p]phos- 
phorylated~ L-PK were pooled and then concen- 
trated using a small DEAE column. The labelled 
enzyme was subjected to aspartyl-prolyl cleavage 
Fig.3. Localisation of protein-bound 32p by autora- 
diography. This figure shows the central section (tracks 
4-10) of fig.2 after autoradiography. 
in 75°70 formic acid. These results showed that the 
majority of the label was incorporated into a 
17 kDa fragment (fig.lb). However, a trace of a 
phosphorylated peptide of 14 kDa was also 
present. 
3.2. Effect of glucagon and phenylephrine on 
phosphorylation of  L-PK in hepatocytes 
Glucagon acts via activation of adenylate cyclase 
to increase cAMP levels within the cell; the effect 
on protein phosphorylation being mediated via 
cAMP-dependent protein kinase. Phenylephrine 
acts, predominately, via the ce-adrenergic receptor 
to alter intracellular Ca 2+ levels, the effects on pro- 
tein phosphorylation being mediated via a distinct 
Ca2+-linked protein kinase. The effect of the latter 
enzyme on pyruvate kinase is unknown. 
Hepatocytes were isolated and the cells in- 
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Fig.4. Incorporation of np into L-type pyruvate kinase 
in response to varying concentrations of (a) 
phenylephrine or (b) glucagon. Phosphorylated pyruvate 
kinase was isolated from hepatocytes, incubated with 
varying concentrations of either phenylephrine or 
glucagon, by immunoprecipitation. Each immunopre- 
cipitate was analysed by SDS-PAGE, and the bands 
corresponding to pyruvate kinase excised and counted, 
after NCS solubilisation, in a liquid scintillation 
counter. The incorporation of np is reported as a 
function of agonist added. In the absence of any added 
compounds the background incorporation was 
70 dpm/#g protein. 
cubated in low phosphate (0.1 mM) Krebs- 
Henseleit buffered saline containing 100#Ci 
nPOaa- per ml hepatocytes (20-25 mg protein/ml 
cell). After 45 min pre-incubation, the ceils were 
exposed to either I#M glucagon or 10#M 
phenylephrine for 10 min. Thereafter the L-PK in 
the cells was isolated as described in section 2.2. 
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Fig.5. Phosphorylated L-PK isolated from either 
glucagon or phenylephrine stimulated hepatocytes, 
before and after aspartyl-prolyl (D/P) cleavage. Tracks: 
1, molecular mass marker; 2, enzyme isolated from 
control hepatocytes; 3, after D/P cleavage of the protein 
in track 2; 4, enzyme isolated from hepatocytes 
incubated with 10#M phenylephrine; 5, after D/P 
cleavage of the protein in track 4; 6, enzyme isolated 
from hepatocytes treated with 1 #M glucagon; 7, after 
D/P cleavage of the protein in track 6. 
Antibody was used to isolate [nP]phosphorylated 
L-PK from the solubilized ammonium sulphate 
pellet. Fig.2 shows that a specific protein of 
57 kDa was obtained from both glucagon-treated 
and control hepatocytes as assessed by SDS- 
PAGE. After autoradiography (fig.3) it was 
demonstrated that the protein-bound 32p was 
associated with the L-PK. The incorporation of 
np  into L-PK was stimulated in the presence of 
1 #M glucagon by 3 .5 -4 fo ld  over that of the 
control. 
When phenylephrine was used an increase in the 
amount of 32p associated with the L-PK was also 
seen. The incorporation showed a dose dependen- 
cy; this is illustrated in fig.4a for phenylephrine 
and fig.4b fo r  glucagon. From the dose-response 
curve we can see that the maximal incorporation of 
np  is different for the two sbbstances, being 4- and 
2-fold for glucagon and phenylephrine, respective- 
ly. The isolated [nP]phosphorylated L-PK was 
subjected to aspartyl-prolyl cleavage. This 
demonstrated that both glucagon and phenyleph- 
rine cause phosphorylation of a 17 kDa polypep- 
tide (fig.5). On average 90% of the label was 
4 
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located in this fragment; he remaining 10°70 of the 
label was associated with a 14 kDa fragment. 
4. DISCUSSION 
Garrison and Wagner [6] have demonstrated 
that pyruvate kinase is one of the proteins which 
can be phosphorylated byeither cAMP-dependent 
or Ca2÷-dependent protein kinases. Our results 
show by direct assay that 1/zM glucagon and 
10/zM phenylephrine r sult in the maximal incor- 
poration of 32p into pyruvate kinase, respectively. 
However, the efficiency of the Ca2+-linked agonist 
is observed to be less than that of glucagon, i.e. the 
incorporation of 32p into pyruvate kinase 
stimulated by phenylephrine is approximately half 
of that seen with glucagon. The reason for this is 
still not clear. In fact, the mechanism by which the 
phosphorylation f pyruvate kinase is increased by 
Ca2+-linked agonists is still not understood. It is 
possible that the calcium stimulates a Ca2÷-sen - 
sitive kinase or inhibits a protein phosphatase. 
Garrison et al. [15] have indicated that neither 
phosphorylase kinase nor protein kinase C, two 
known Ca2÷-dependent protein kinases, appears to 
mediate this phosphorylation in hepatocytes. A re- 
cent report has demonstrated that pyruvate kinase 
is phosphorylated in vitro by a Ca2÷/calmodulin - 
dependent protein kinase [8], which may account 
for the observed phosphorylation in hepatocytes in 
response to agents which mobilize calcium, e.g. 
epinephrine, vasopressin, angiotensin II and 
A23187 [6]. 
Blackmore and Exton [16] reported that the ef- 
fects of the Ca2+-linked hormones on phospho- 
rylase are mediated by phosphorylase kinase. 
Recent studies, however, indicate that their effects 
on pyruvate kinase are not mediated through 
phosphorylase kinase [17]. The exact mechanism 
by which hormones regulate protein phosphatases 
in liver is not known. 
Pyruvate kinase has been shown to be 
phosphorylated by either cAMP or Ca2+-mediated 
hormones in hepatocytes. Whether these two dif- 
ferent sorts of hormone phosphorylate he same 
site of the enzyme is not clear. By comparison the 
rabbit muscle glycogen synthetase is known to 
possess multiple sites for phosphorylation [7]. Site 
1 is phosphorylated by cAMP-dependent protein 
kinase, whilst site 2 is phosphorylated by either 
cAMP- or Ca2÷-sensitive protein kinases. Our 
results demonstrated that isolation of [32p]phos- 
phorylated L-PK from glucagon treated or as a 
result of in vitro phosphorylation using cAMP- 
dependent protein kinase followed by aspartyl- 
prolyl cleavage yields a [32p]phosphorylation site 
located in a 17 kDa peptide fragment. This same 
fragment is also phosphorylated in response to the 
Ca2÷-mediated agonist phenylephrine. In addition 
to the 17 kDa peptide, we also observed a small 
amount of a 14 kDa fragment. 
The complete nucleotide sequence for rat liver 
pyruvate kinase has been determined [18,19] and 
the amino acid sequence of the enzyme predicted. 
These results indicate that there are two aspartyl- 
prolyl sites in the enzyme, and the protein should 
be cleaved into three fragments of 16.9, 28.5 and 
13.5 kDa. The N-terminal of the enzyme is located 
in the 16.9 kDa peptide and the C-terminal in the 
13.5 kDa peptide. The major phosphorylation site 
would therefore appear to be near the N-terminal 
for both the cAMP-dependent [20] and 
CaZ÷-linked protein kinases. The identity of the 
minor fragment is, however, more problematical. 
It could either demonstrate a second, minor site 
near the C-terminal of the enzyme or it could arise 
through further cleavage of the 17 kDa 
phosphorylated polypeptide fragment in the acidic 
conditions used. The relationship between these 
polypeptides i  still under investigation. 
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